-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Upgrades Galderma to Overweight, Boosts PT

MT Newswires·07/30/2026 08:33:16
Listen to the news
08:33 AM EDT, 07/30/2026 (MT Newswires) -- Morgan Stanley on Thursday upgraded Swiss dermatology company Galderma (GALD.SW) to overweight from equal weight and raised its price target to 210 francs from 160 francs. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)